Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bayes-Genis

Showing results (521-530 of 645) with videos related to

Pageof 65
Sort By:
ESC Heart Failure|May 19, 2022
Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertensionPau Codina, Mar Domingo, Elena Barceló, et al.
Revista Espanola De Cardiologia (English Ed.)|September 29, 2019
Renal denervation for the treatment of resistant hypertension in Spain. The Flex-Spyral RegistryOriol Rodriguez-Leor, Julián Segura, José Antonio García Donaire, et al.
Journal of the American College of Cardiology|October 21, 2017
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF SubanalysisAntoni Bayes-Genis, Julio Núñez, Faiez Zannad, et al.
Journal of the American Heart Association|July 13, 2019
External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart FailureKhibar Salah, Susan Stienen, Andreas H M Moons, et al.
Journal of the American College of Cardiology|November 17, 2024
Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary StudyKershaw V Patel, Zainali Chunawala, Subodh Verma, et al.
European Journal of Heart Failure|July 18, 2025
Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-OncologyAmina Rakisheva, Dimitrios Farmakis, Andrea Attanasio, et al.
ESC Heart Failure|April 28, 2026
Evaluation and management of recent onset cardiomyopathy in the current era of heart failure therapeutics. A clinical consensus statement of the Heart Failure Association of the ESCHadi Skouri, Amr Abdin, Wilfried Mullens, et al.
Frontiers in Cardiovascular Medicine|October 7, 2022
Electrophysiological effects of adipose graft transposition procedure (AGTP) on the post-myocardial infarction scar: A multimodal characterization of arrhythmogenic substrateRaquel Adeliño, Daina Martínez-Falguera, Carolina Curiel, et al.
European Journal of Heart Failure|June 22, 2019
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrationsChristian Mueller, Kenneth McDonald, Rudolf A de Boer, et al.
European Journal of Heart Failure|June 16, 2007
Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failureAntoni Bayes-Genis, Rafael Vazquez, Teresa Puig, et al.
Pageof 65

Showing results (521-530 of 645) with videos related to

Sort By:
Pageof 65
ESC Heart Failure|May 19, 2022
Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertensionPau Codina, Mar Domingo, Elena Barceló, et al.
Revista Espanola De Cardiologia (English Ed.)|September 29, 2019
Renal denervation for the treatment of resistant hypertension in Spain. The Flex-Spyral RegistryOriol Rodriguez-Leor, Julián Segura, José Antonio García Donaire, et al.
Journal of the American College of Cardiology|October 21, 2017
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF SubanalysisAntoni Bayes-Genis, Julio Núñez, Faiez Zannad, et al.
Journal of the American Heart Association|July 13, 2019
External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart FailureKhibar Salah, Susan Stienen, Andreas H M Moons, et al.
Journal of the American College of Cardiology|November 17, 2024
Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary StudyKershaw V Patel, Zainali Chunawala, Subodh Verma, et al.
European Journal of Heart Failure|July 18, 2025
Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-OncologyAmina Rakisheva, Dimitrios Farmakis, Andrea Attanasio, et al.
ESC Heart Failure|April 28, 2026
Evaluation and management of recent onset cardiomyopathy in the current era of heart failure therapeutics. A clinical consensus statement of the Heart Failure Association of the ESCHadi Skouri, Amr Abdin, Wilfried Mullens, et al.
Frontiers in Cardiovascular Medicine|October 7, 2022
Electrophysiological effects of adipose graft transposition procedure (AGTP) on the post-myocardial infarction scar: A multimodal characterization of arrhythmogenic substrateRaquel Adeliño, Daina Martínez-Falguera, Carolina Curiel, et al.
European Journal of Heart Failure|June 22, 2019
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrationsChristian Mueller, Kenneth McDonald, Rudolf A de Boer, et al.
European Journal of Heart Failure|June 16, 2007
Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failureAntoni Bayes-Genis, Rafael Vazquez, Teresa Puig, et al.
Pageof 65